A Case of Therapy-Related Acute Leukemia With Mixed Phenotype With BCR-ABL1 After Treatment of Diffuse Large B-Cell Lymphoma

Ann Lab Med. 2017 Mar;37(2):166-168. doi: 10.3343/alm.2017.37.2.166.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / pathology
  • Female
  • Flow Cytometry
  • Fusion Proteins, bcr-abl / genetics*
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Immunophenotyping
  • Leukemia / diagnosis*
  • Leukemia / etiology
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Phenotype
  • Rituximab / administration & dosage

Substances

  • Granulocyte Colony-Stimulating Factor
  • Rituximab
  • Fusion Proteins, bcr-abl